Intuitive Surgical Company Profile (NASDAQ:ISRG)

About Intuitive Surgical (ISRG)

Intuitive Surgical logoIntuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon's hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company's instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ISRG
  • CUSIP: 46120E60
Key Metrics:
  • Previous Close: $745.95
  • 50 Day Moving Average: $727.68
  • 200 Day Moving Average: $683.91
  • 52-Week Range: $562.60 - $757.99
  • Trailing P/E Ratio: 39.95
  • Foreward P/E Ratio: 28.21
  • P/E Growth: 2.69
  • Market Cap: $29.02B
  • Outstanding Shares: 38,786,000
  • Beta: 0.55
Profitability:
  • Net Margins: 27.21%
  • Return on Equity: 14.24%
  • Return on Assets: 12.74%
Debt:
  • Current Ratio: 5.45%
  • Quick Ratio: 5.14%

Analyst Ratings

Consensus Ratings for Intuitive Surgical (NASDAQ:ISRG) (?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $734.08 (1.90% downside)

Analysts' Ratings History for Intuitive Surgical (NASDAQ:ISRG)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
2/14/2017Bank of America CorpSet Price TargetBuy$770.00 -> $800.00N/AView Rating Details
1/25/2017Canaccord GenuityReiterated RatingBuyN/AView Rating Details
1/14/2017WedbushReiterated RatingOutperform$800.00N/AView Rating Details
1/4/2017Evercore ISIDowngradeBuy -> Hold$690.00N/AView Rating Details
10/21/2016Barclays PLCReiterated RatingOverweight$750.00 -> $760.00N/AView Rating Details
10/19/2016Royal Bank of CanadaSet Price TargetHold$750.00 -> $760.00N/AView Rating Details
10/13/2016Wells Fargo & CoInitiated CoverageOutperformN/AView Rating Details
9/20/2016JPMorgan Chase & Co.Reiterated RatingBuyN/AView Rating Details
9/20/2016BTIG ResearchReiterated RatingHoldN/AView Rating Details
9/19/2016Leerink SwannReiterated RatingOutperform$780.00N/AView Rating Details
8/26/2016Raymond James Financial, Inc.Initiated CoverageOutperformN/AView Rating Details
7/21/2016Northland SecuritiesDowngradeMarket Perform -> Under Perform$600.00N/AView Rating Details
7/20/2016Citigroup IncBoost Price TargetBuy$723.00 -> $779.00N/AView Rating Details
7/20/2016Piper Jaffray CompaniesReiterated RatingNeutral$610.00 -> $700.00N/AView Rating Details
7/20/2016Stifel NicolausBoost Price TargetBuy$700.00 -> $800.00N/AView Rating Details
6/2/2016Goldman Sachs Group IncDowngradeBuy -> Neutral$633.00 -> $674.00N/AView Rating Details
4/20/2016Morgan StanleyReiterated RatingBuyN/AView Rating Details
4/14/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
1/22/2016William BlairReiterated RatingBuyN/AView Rating Details
7/22/2015Jefferies Group LLCBoost Price TargetBuy$616.00 -> $675.00N/AView Rating Details
(Data available from 3/23/2015 forward)

Earnings

Earnings History for Intuitive Surgical (NASDAQ:ISRG)
Earnings by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Earnings History by Quarter for Intuitive Surgical (NASDAQ:ISRG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/17/2017        
1/24/2017Q416$5.99$6.09$739.65 million$757.00 millionViewN/AView Earnings Details
10/18/2016Q3$5.13$6.19$650.49 million$682.90 millionViewListenView Earnings Details
7/19/2016Q216$4.97$5.62$640.69 million$670.00 millionViewListenView Earnings Details
4/19/2016Q1$4.33$4.42$593.08 million$594.50 millionViewListenView Earnings Details
1/21/2016Q4$5.04$5.89$655.32 million$676.50 millionViewListenView Earnings Details
10/20/2015Q3$4.23$5.24$580.37 million$590.00 millionViewListenView Earnings Details
7/21/2015Q2$3.98$4.57$566.86 million$586.10 millionViewListenView Earnings Details
4/21/2015Q1$3.87$3.57$535.10 million$532.10 millionViewListenView Earnings Details
1/22/2015Q4$4.38$4.92$601.00 millionViewListenView Earnings Details
10/21/2014Q314$3.72$3.92$515.44 million$550.00 millionViewListenView Earnings Details
7/22/2014Q214$2.82$3.73$502.23 million$512.00 millionViewListenView Earnings Details
4/22/2014Q114$3.31$1.13$507.04 million$464.70 millionViewListenView Earnings Details
1/23/2014Q413$3.81$4.28$576.00 million$576.20 millionViewListenView Earnings Details
10/17/2013Q313$3.40$3.99$525.47 million$499.00 millionViewListenView Earnings Details
7/18/2013Q2 2013$4.04$3.90$594.58 million$578.50 millionViewListenView Earnings Details
4/18/2013Q1 2013$4.02$4.56$583.59 million$611.40 millionViewListenView Earnings Details
1/22/2013Q4 2012$4.02$4.25$584.36 million$609.30 millionViewListenView Earnings Details
10/16/2012$3.51$4.46ViewN/AView Earnings Details
7/19/2012$3.57$3.75ViewN/AView Earnings Details
4/17/2012$3.15$3.50ViewN/AView Earnings Details
1/19/2012$3.35$3.75ViewN/AView Earnings Details
10/18/2011$2.81$3.05ViewN/AView Earnings Details
7/19/2011$2.71$2.91ViewN/AView Earnings Details
4/19/2011$2.49$2.59ViewN/AView Earnings Details
1/20/2011$2.25$3.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intuitive Surgical (NASDAQ:ISRG)
Current Year EPS Consensus Estimate: $23.49 EPS
Next Year EPS Consensus Estimate: $26.53 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20162$5.35$5.88$5.62
Q1 20171$3.96$3.96$3.96
Q2 20171$4.55$4.55$4.55
Q3 20171$4.89$4.89$4.89
Q4 20171$5.69$5.69$5.69
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Intuitive Surgical (NASDAQ:ISRG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Intuitive Surgical (NASDAQ:ISRG)
Insider Ownership Percentage: 3.10%
Institutional Ownership Percentage: 91.16%
Insider Trades by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Insider Trades by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/15/2017Amal M JohnsonDirectorSell1,000$750.00$750,000.00View SEC Filing  
3/15/2017David J RosaEVPSell5,000$750.00$3,750,000.00View SEC Filing  
3/15/2017Jamie SamathVPSell4,268$750.00$3,201,000.00View SEC Filing  
3/15/2017Marshall MohrCFOSell4,250$750.00$3,187,500.00View SEC Filing  
3/1/2017Salvatore BrognaEVPSell6,628$736.80$4,883,510.40View SEC Filing  
2/24/2017Curet MyriamSVPSell222$729.80$162,015.60View SEC Filing  
2/21/2017Mark J MeltzerSVPSell8,750$724.82$6,342,175.00View SEC Filing  
2/7/2017Colin MoralesSVPSell1,000$703.99$703,990.00View SEC Filing  
2/2/2017Marshall MohrCFOSell2,000$700.00$1,400,000.00View SEC Filing  
1/27/2017Lonnie M SmithDirectorSell1,000$684.38$684,380.00View SEC Filing  
12/13/2016David J RosaEVPSell7,200$650.00$4,680,000.00View SEC Filing  
12/13/2016Lonnie M SmithDirectorSell1,000$650.00$650,000.00View SEC Filing  
11/17/2016Lonnie M SmithDirectorSell275$646.50$177,787.50View SEC Filing  
11/7/2016Gary S GuthartCEOSell13,515$680.68$9,199,390.20View SEC Filing  
8/22/2016Mark J MeltzerSVPSell3,000$688.33$2,064,990.00View SEC Filing  
8/4/2016Alan J LevyDirectorSell3,188$694.11$2,212,822.68View SEC Filing  
8/1/2016Gary S GuthartCEOSell13,400$698.00$9,353,200.00View SEC Filing  
7/27/2016Curet MyriamSVPSell4,250$684.39$2,908,657.50View SEC Filing  
7/27/2016Marshall MohrCFOSell5,000$684.09$3,420,450.00View SEC Filing  
6/2/2016Salvatore BrognaEVPSell600$630.96$378,576.00View SEC Filing  
6/1/2016Salvatore BrognaEVPSell20,406$632.66$12,910,059.96View SEC Filing  
5/17/2016Curet MyriamSVPSell530$629.36$333,560.80View SEC Filing  
5/17/2016Lonnie M SmithDirectorSell2,000$627.23$1,254,460.00View SEC Filing  
5/3/2016George Stalk JrDirectorSell7,644$618.70$4,729,342.80View SEC Filing  
5/2/2016Marshall MohrCFOSell5,000$631.63$3,158,150.00View SEC Filing  
4/27/2016Mark J MeltzerSVPSell16,625$631.52$10,499,020.00View SEC Filing  
4/26/2016Alan J LevyDirectorSell542$631.72$342,392.24View SEC Filing  
4/25/2016Amal M JohnsonDirectorSell2,500$640.00$1,600,000.00View SEC Filing  
4/22/2016Curet MyriamSVPSell8,173$637.75$5,212,330.75View SEC Filing  
4/22/2016Eric H HalvorsonDirectorSell5,688$639.21$3,635,826.48View SEC Filing  
3/14/2016Eric H HalvorsonDirectorSell4,438$593.16$2,632,444.08View SEC Filing  
3/14/2016Mark J MeltzerSVPSell12,500$589.00$7,362,500.00View SEC Filing  
3/11/2016Curet MyriamSVPSell2,000$582.50$1,165,000.00View SEC Filing  
3/11/2016Jamie SamathVPSell8,026$575.95$4,622,574.70View SEC Filing  
3/10/2016Alan J LevyDirectorSell5,000$569.14$2,845,700.00View SEC Filing  
3/7/2016Colin MoralesSVPSell2,500$575.00$1,437,500.00View SEC Filing  
3/4/2016Colin MoralesSVPSell884$571.49$505,197.16View SEC Filing  
3/3/2016Marshall MohrCFOSell2,500$575.00$1,437,500.00View SEC Filing  
3/2/2016Salvatore BrognaEVPSell1,882$567.37$1,067,790.34View SEC Filing  
2/19/2016Colin MoralesSVPSell5,530$542.83$3,001,849.90View SEC Filing  
2/4/2016Curet MyriamSVPSell2,000$551.00$1,102,000.00View SEC Filing  
2/4/2016Marshall MohrCFOSell2,500$550.00$1,375,000.00View SEC Filing  
1/29/2016Mark J. MeltzerSVPSell4,125$527.59$2,176,308.75View SEC Filing  
12/14/2015Salvatore BrognaEVPSell2,734$530.00$1,449,020.00View SEC Filing  
11/20/2015Mark J. MeltzerSVPSell1,625$515.00$836,875.00View SEC Filing  
10/26/2015Mark J. MeltzerSVPSell2,500$498.37$1,245,925.00View SEC Filing  
10/23/2015Lonnie M. SmithDirectorSell10,328$500.00$5,164,000.00View SEC Filing  
9/1/2015Salvatore BrognaEVPSell374$501.99$187,744.26View SEC Filing  
8/18/2015George Stalk JrDirectorSell4,726$532.03$2,514,373.78View SEC Filing  
7/27/2015Gary S GuthartCEOSell17,255$541.98$9,351,864.90View SEC Filing  
7/27/2015Mark J MeltzerSVPSell4,750$542.03$2,574,642.50View SEC Filing  
7/24/2015David J RosaEVPSell2,800$550.20$1,540,560.00View SEC Filing  
7/24/2015Jamie SamathVPSell5,000$550.00$2,750,000.00View SEC Filing  
7/24/2015Lonnie M SmithDirectorSell20,000$544.62$10,892,400.00View SEC Filing  
6/9/2015Alan J LevyDirectorSell417$495.41$206,585.97View SEC Filing  
6/8/2015Gary S GuthartCEOSell17,840$492.16$8,780,134.40View SEC Filing  
5/29/2015Lonnie M SmithDirectorSell2,000$488.68$977,360.00View SEC Filing  
5/27/2015Curet MyriamSVPSell1,000$489.35$489,350.00View SEC Filing  
5/18/2015Colin MoralesSVPSell13,824$503.29$6,957,480.96View SEC Filing  
4/28/2015Curet MyriamSVPSell261$504.54$131,684.94View SEC Filing  
4/27/2015Jerome J McnamaraEVPSell15,000$504.06$7,560,900.00View SEC Filing  
4/27/2015Marshall MohrCFOSell10,000$504.08$5,040,800.00View SEC Filing  
4/24/2015Lonnie M SmithDirectorSell20,000$508.03$10,160,600.00View SEC Filing  
3/2/2015Salvatore BrognaSVPSell1,375$500.98$688,847.50View SEC Filing  
2/6/2015Mark J RubashDirectorSell5,000$520.00$2,600,000.00View SEC Filing  
1/27/2015Jerome J McnamaraEVPSell15,000$511.32$7,669,800.00View SEC Filing  
1/27/2015Lonnie M SmithDirectorSell20,000$511.31$10,226,200.00View SEC Filing  
1/27/2015Marshall MohrCFOSell5,000$511.14$2,555,700.00View SEC Filing  
12/8/2014Lonnie M SmithDirectorSell1,700$511.24$869,108.00View SEC Filing  
12/1/2014Salvatore BrognaSVPSell1,375$515.87$709,321.25View SEC Filing  
11/24/2014Colin MoralesSVPSell9,565$520.82$4,981,643.30View SEC Filing  
10/31/2014Marshall MohrCFOSell7,500$500.00$3,750,000.00View SEC Filing  
10/30/2014Floyd D Md LoopDirectorSell2,125$488.95$1,039,018.75View SEC Filing  
10/27/2014Floyd D Md LoopDirectorSell15,209$475.71$7,235,073.39View SEC Filing  
10/27/2014Jerome J McnamaraEVPSell15,000$473.76$7,106,400.00View SEC Filing  
10/27/2014Marshall MohrCFOSell2,500$473.50$1,183,750.00View SEC Filing  
9/2/2014Salvatore BrognaSVPSell12,626$472.06$5,960,229.56View SEC Filing  
8/26/2014Colin MoralesSVPSell4,105$478.66$1,964,899.30View SEC Filing  
7/28/2014Jerome J McnamaraEVPSell9,167$465.59$4,268,063.53View SEC Filing  
7/25/2014Colin MoralesSVPSell2,000$461.99$923,980.00View SEC Filing  
2/27/2014Colin MoralesSVPSell1,000$445.00$445,000.00View SEC Filing  
12/3/2012Lonnie M SmithChairmanSell1,000$525.98$525,980.00View SEC Filing  
9/4/2012Salvatore BrognaSVPSell1,250$490.25$612,812.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Intuitive Surgical (NASDAQ:ISRG)
Latest Headlines for Intuitive Surgical (NASDAQ:ISRG)
Source:
DateHeadline
businesswire.com logoOutset Medical Announces Appointment of Gus Castello as Chief Operating Officer (NASDAQ:ISRG)
www.businesswire.com - March 22 at 6:11 PM
fool.com logoBetter Buy: Intuitive Surgical, Inc. vs. Johnson & Johnson (NASDAQ:ISRG)
www.fool.com - March 21 at 11:30 AM
finance.yahoo.com logoIntuitive Surgical Reports New Employee Option Grants for March 2017 (NASDAQ:ISRG)
finance.yahoo.com - March 13 at 5:50 PM
thestreet.com logoThese 3 Big, Hated Stocks Could See Short Squeezes in March (NASDAQ:ISRG)
www.thestreet.com - March 8 at 6:47 PM
finance.yahoo.com logoStock Market News for March 08, 2017 (NASDAQ:ISRG)
finance.yahoo.com - March 8 at 6:47 PM
fool.com logo3 Healthcare Stocks to Invest In (NASDAQ:ISRG)
www.fool.com - February 25 at 5:44 PM
streetinsider.com logoForm 4 INTUITIVE SURGICAL INC For: Feb 17 Filed by: Myriam Curet (NASDAQ:ISRG)
www.streetinsider.com - February 22 at 11:15 PM
streetinsider.com logoForm 4 INTUITIVE SURGICAL INC For: Feb 17 Filed by: GUTHART GARY S (NASDAQ:ISRG)
www.streetinsider.com - February 22 at 6:12 PM
us.rd.yahoo.com logoBaron Opportunity Fund Comments on Intuitive Surgical (NASDAQ:ISRG)
us.rd.yahoo.com - February 22 at 12:35 PM
streetinsider.com logoForm 4 INTUITIVE SURGICAL INC For: Feb 15 Filed by: Rosa David J. (NASDAQ:ISRG)
www.streetinsider.com - February 18 at 11:03 AM
nasdaq.com logoNoteworthy Tuesday Option Activity: ISRG, MMM, MGM (NASDAQ:ISRG)
www.nasdaq.com - February 14 at 7:22 PM
finance.yahoo.com logoBaron Funds' Fifth Avenue Growth Fund Comments on Intuitive Surgical (NASDAQ:ISRG)
finance.yahoo.com - February 13 at 7:03 PM
finance.yahoo.com logoIntuitive Surgical Reports New Employee Option Grants for February 2017 (NASDAQ:ISRG)
finance.yahoo.com - February 13 at 7:03 PM
fool.com logoBetter Buy: Intuitive Surgical, Inc. vs. Accuray Incorporated (NASDAQ:ISRG)
www.fool.com - February 13 at 9:31 AM
finance.yahoo.com logoINTUITIVE SURGICAL INC Financials (NASDAQ:ISRG)
finance.yahoo.com - February 9 at 6:56 PM
fool.com logoIntuitive Surgical's Quarter in 6 Metrics (NASDAQ:ISRG)
www.fool.com - February 9 at 9:31 AM
biz.yahoo.com logoINTUITIVE SURGICAL INC Files SEC form 10-K, Annual Report (NASDAQ:ISRG)
us.rd.yahoo.com - February 8 at 6:45 PM
biz.yahoo.com logoINTUITIVE SURGICAL INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:ISRG)
biz.yahoo.com - February 8 at 6:45 PM
fool.com logoWhy Intuitive Surgical Is Increasing R&D Spending by Over 30% (NASDAQ:ISRG)
www.fool.com - February 7 at 10:58 AM
marketwatch.com logo10-K: INTUITIVE SURGICAL INC (NASDAQ:ISRG)
www.marketwatch.com - February 6 at 6:03 PM
fool.com logoHere's What Allowed This "Cutting-Edge" Stock to Jump 9% in January (NASDAQ:ISRG)
www.fool.com - February 3 at 10:58 AM
fool.com logo6 Must-See Quotes From Intuitive Surgical's Management (NASDAQ:ISRG)
www.fool.com - February 1 at 1:37 PM
streetinsider.com logoForm 4 INTUITIVE SURGICAL INC For: Jan 27 Filed by: SMITH LONNIE M (NASDAQ:ISRG)
www.streetinsider.com - January 28 at 12:59 AM

Social

Frequently Asked Questions for Intuitive Surgical (NASDAQ:ISRG)

What is Intuitive Surgical's stock symbol?

Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."

How were Intuitive Surgical's earnings last quarter?

Intuitive Surgical, Inc. (NASDAQ:ISRG) issued its earnings results on Tuesday, January, 24th. The company reported $6.09 earnings per share for the quarter, beating analysts' consensus estimates of $5.99 by $0.10. The company had revenue of $757 million for the quarter, compared to the consensus estimate of $739.65 million. Intuitive Surgical had a return on equity of 14.24% and a net margin of 27.21%. The firm's quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.89 EPS.

When will Intuitive Surgical make its next earnings announcement?

Intuitive Surgical is scheduled to release their next quarterly earnings announcement on Monday, April, 17th 2017.

Where is Intuitive Surgical's stock going? Where will Intuitive Surgical's stock price be in 2017?

18 analysts have issued twelve-month price targets for Intuitive Surgical's shares. Their predictions range from $600.00 to $800.00. On average, they anticipate Intuitive Surgical's stock price to reach $734.08 in the next twelve months.

What are analysts saying about Intuitive Surgical stock?

Here are some recent quotes from research analysts about Intuitive Surgical stock:

  • 1. Canaccord Genuity analysts commented, "ISRG is shaping up to be one of the most compelling large-cap med-tech stocks in the sector, in our view; thus, we stay buyers of the stock. Coming off one of the most impressive years in its nearly two-decade run - delivering 13% revenue growth and 26% pro-forma EPS growth, and building its cash position to ~$5 Billion ' ISRG outlined in detail what we believe is the most robust new product pipeline in its history (which we discuss in detail below). Granted, the firm guided to a significant ramp in OpEx in 2017 (+15-18% Y/Y) - primary R&D spending (i.e. $80M in accelerated R&D projects in 2017) - to fund important clinical trials (cost/economic studies, molecular imaging), augment development of key projects (catheter robotics, new molecular imaging modalities, diagnostics/biopsy platform) and 'grease' the regulatory machinery around the world (China, Japan, Brazil, and US). This will undoubtedly tamp down pro forma EPS growth in 2017E (we now model 5% Y/Y vs. 13% previously); however, we think the launch of SP during 2017, coupled with OpEx leverage (as the R&D surge abates next year), will accelerate EPS growth back to the mid-teens at least in 2018E (we model 16% Y/ Y growth). With a few of the aforementioned, unique, compelling new revenue drivers poised to join the party in 2019 and beyond, we think bears will find it hard to bet against the 'Surge.' To wit, we view the current spending surge as a bullish indication, positively reinforcing how management views business trends playing out over the next several years. We reiterate a Buy rating and $800 target price (which excludes over $75 in cash/share after the $2B accelerated share repurchase slated for immediate execution)." (1/25/2017)
  • 2. According to Zacks Investment Research, "Over the past one year Intuitive Surgical has outperformed the broader industry trends in terms of price performance. Additionally, a favorable estimate revision trend for the current year holds considerable promise for the stock. Intuitive Surgical has been gaining prominence in the niche markets, courtesy of the growing adoption of the da Vinci system (a surgical platform) among physicians and overall growth in global procedures. Furthermore, incremental spending on product development and higher investments in international markets are prudent moves that will drive long-term growth. However, Intuitive Surgical faces the risk of lower capital spending by hospitals. Thus a major source of risk is pricing pressure. Additionally, challenging foreign exchange movements are likely to mar prospects." (1/17/2017)
  • 3. JPMorgan Chase & Co. analysts commented, "Over the weekend, we attended the second annual Global Symposium on Robotic Assisted and Minimally Invasive Hernia Repair, which was a gathering of >250 general surgeons in New York. The meeting was positive for Intuitive Surgical (ISRG), as interest in robotic hernia repair has increased since last year, with a number of presentations highlighting both clinical and cost data, while there was broader acknowledgement that robotics is the future for hernia repair (including by ISRG’s Chief Medical Officer, who not surprisingly, spoke positively about potential future adoption, with potential for it to eventually reach 40-50% penetration). Following the conference, along with our recent physician survey (see note here), we are increasingly confident that hernia is a legitimate opportunity for ISRG, and should continue to be a primary driver of sustainable procedure growth over the near to intermediate term." (9/20/2016)

Who owns Intuitive Surgical stock?

Intuitive Surgical's stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (5.67%), State Street Corp (4.21%), Baillie Gifford & Co. (4.03%), Brown Advisory Inc. (1.92%), Edgewood Management LLC (1.71%) and Norges Bank (0.66%). Company insiders that own Intuitive Surgical stock include Alan J Levy, Amal M Johnson, Colin Morales, Curet Myriam, David J Rosa, Eric H Halvorson, Gary S Guthart, George Stalk Jr, Jamie Samath, Jerome J Mcnamara, Lonnie M Smith, Mark J Meltzer, Marshall Mohr and Salvatore Brogna.

Who sold Intuitive Surgical stock? Who is selling Intuitive Surgical stock?

Intuitive Surgical's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Orbimed Advisors LLC, Brown Advisory Inc., Two Sigma Investments LP, Sandler Capital Management, Credit Agricole S A, Baird Financial Group Inc. and Baillie Gifford & Co.. Company insiders that have sold Intuitive Surgical stock in the last year include Alan J Levy, Amal M Johnson, Colin Morales, Curet Myriam, David J Rosa, Eric H Halvorson, Gary S Guthart, George Stalk Jr, Jamie Samath, Lonnie M Smith, Mark J Meltzer, Marshall Mohr and Salvatore Brogna.

Who bought Intuitive Surgical stock? Who is buying Intuitive Surgical stock?

Intuitive Surgical's stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Renaissance Technologies LLC, State Street Corp, Janus Capital Management LLC, Asset Management One Co. Ltd., Russell Investments Group Ltd., NN Investment Partners Holdings N.V. and Guggenheim Capital LLC.

How do I buy Intuitive Surgical stock?

Shares of Intuitive Surgical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Intuitive Surgical stock cost?

One share of Intuitive Surgical stock can currently be purchased for approximately $748.31.

Intuitive Surgical (ISRG) Chart for Thursday, March, 23, 2017

This page was last updated on 3/23/2017 by MarketBeat.com Staff